What is nortriptyline
Pro Research Analysisby 
Searched over 200M research papers
Understanding Nortriptyline: Uses, Efficacy, and Mechanisms
Introduction to Nortriptyline
Nortriptyline is a tricyclic antidepressant (TCA) commonly prescribed for various medical conditions. It is primarily used to treat depression but has also been explored for other therapeutic uses, including neuropathic pain and post-stroke recovery.
Nortriptyline for Neuropathic Pain
Efficacy in Neuropathic Pain Management
Nortriptyline is occasionally used to manage chronic neuropathic pain, which is pain resulting from nerve damage. Despite its use, evidence supporting its efficacy is limited. A review of six studies involving 310 participants with various neuropathic pain conditions found that nortriptyline's effectiveness was comparable to other treatments like gabapentin, morphine, and other antidepressants, but the quality of evidence was very low1. The studies were methodologically flawed, often small in size, and potentially biased, leading to inconclusive results regarding nortriptyline's superiority or equivalence to other treatments.
Adverse Effects
The adverse effects of nortriptyline were inconsistently reported across studies. However, it was noted that more participants experienced adverse events with nortriptyline compared to placebo, with similar adverse event rates when compared to other antidepressants and gabapentin1. No serious adverse events or deaths were reported in the studies reviewed.
Nortriptyline in Depression and Post-Stroke Recovery
Comparative Efficacy with Fluoxetine
In a study comparing nortriptyline and fluoxetine for treating depression and aiding recovery after a stroke, nortriptyline was found to be more effective in treating post-stroke depression and improving activities of daily living2. The study involved 104 patients and demonstrated that nortriptyline had a significantly higher response rate in reducing depression symptoms compared to fluoxetine and placebo. However, neither drug showed significant effects on cognitive or social functioning recovery.
Role in Bereavement-Related Depression
Nortriptyline has also been studied for its efficacy in treating major depressive episodes related to bereavement. In a controlled study, nortriptyline alone or combined with interpersonal psychotherapy was superior to placebo in achieving remission of depression4. The combination of nortriptyline and psychotherapy had the highest treatment completion rates, suggesting a synergistic effect.
Neuroprotective Effects of Nortriptyline
Protection Against Cerebral Ischemia
Nortriptyline has shown potential neuroprotective effects in models of cerebral ischemia. It was found to inhibit mitochondrial permeability transition, a process implicated in acute neuronal death, thereby reducing cell death and improving neurological outcomes in mice subjected to middle cerebral artery occlusion3. This suggests that nortriptyline may protect against cerebral ischemia by maintaining mitochondrial function and preventing apoptosis.
Antitumor Properties
Effects on Bladder Cancer Cells
Recent research has indicated that nortriptyline may have antitumor effects, particularly in bladder cancer. It induces apoptosis in bladder cancer cells through both mitochondria-mediated and death receptor-mediated pathways5. Nortriptyline increases the expression of pro-apoptotic factors and decreases anti-apoptotic proteins, leading to reduced tumor growth in vivo. This highlights its potential as a chemotherapeutic agent for bladder cancer.
Conclusion
Nortriptyline is a versatile tricyclic antidepressant with applications extending beyond depression treatment. While its efficacy in neuropathic pain management remains uncertain due to low-quality evidence, it has shown promise in treating post-stroke depression and bereavement-related major depressive episodes. Additionally, nortriptyline exhibits neuroprotective properties in cerebral ischemia and potential antitumor effects in bladder cancer. Further research is needed to fully understand and optimize its therapeutic applications.
Sources and full results
Most relevant research papers on this topic
Nortriptyline for neuropathic pain in adults.
Nortriptyline is not a first-line treatment for chronic neuropathic pain in adults, as it lacks sufficient evidence and is associated with adverse events.
Very Rigorous Journal
Highly CitedNortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
Nortriptyline is superior to fluoxetine in treating poststroke depression and improving recovery of daily living activities, but both medications show no significant effect on cognitive or social functioning.
RCTHighly CitedNortriptyline Protects Mitochondria and Reduces Cerebral Ischemia/Hypoxia Injury
Nortriptyline is neuroprotective against cerebral ischemia, suggesting it could be a valuable therapeutic target for acute neurodegeneration.
Non-RCT
Animal StudyHighly CitedTreatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy.
Nortriptyline and interpersonal psychotherapy effectively treat bereavement-related major depressive episodes, with the combination showing the highest treatment completion rate.
RCTHighly CitedNortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo.
Nortriptyline induces both intrinsic and extrinsic apoptosis in bladder cancer cells, potentially making it a useful chemotherapeutic agent for bladder cancer in humans.
In Vitro Study
Rigorous JournalNortriptyline Hydrochloride Solubility-pH Profiles in a Saline Phosphate Buffer: Drug-Phosphate Complexes and Multiple pHmax Domains with a Gibbs Phase Rule "Soft" Constraints.
Nortriptyline hydrochloride's solubility in a phosphate-containing aqueous suspension varies with pH, highlighting the importance of considering competing counterions in drug formulation.
A Comparison of Nortriptyline and Amitriptyline in Depression
Nortriptyline shows potential as an effective anti-depressant, compared to amitriptyline, with both showing promising results in clinical trials.
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
Nortriptyline treatment for depression involves 50-70% norepinephrine transporter occupancy in the brain, suggesting that more than 50% central NET occupancy is appropriate for effective treatment.
Observational StudyRigorous JournalA Randomized Trial of Nortriptyline for Severe Chronic Tinnitus: Effects on Depression, Disability, and Tinnitus Symptoms
Nortriptyline effectively decreases depression, functional disability, and tinnitus loudness in patients with severe chronic tinnitus.
RCTHighly CitedA double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders.
Nortriptyline showed significant effects in reducing impulsive drinking in male alcoholics with antisocial personality disorder, while bromocriptine showed no significant effects.
RCTHighly Cited